Qian Xie

Dr. Qian Xie

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RMRong Ma
Rong Ma
DLDanni Lu
Danni Lu
JWJian Wang
Jian Wang
QXQian Xie
Qian Xie
JGJialiang Guo
Jialiang Guo
Chiral drugs generally exhibit differences in activity because they bind differently to their target receptor. The Chinese medicine borneol ('Bing Pian' in Chinese) is a bicyclic monoterpenoid with a wide range of biological activities. Three kinds of Chinese medicines comprising borneol are used clinically, namely, L-Borneolum ('Ai Pian' in Chinese), Borneolum ('Tian Ran Bing Pian' in Chinese), and synthetic borneol ('He Cheng Bing Pian' in Chinese). The three kinds of borneol have different stereochemical configurations, but their clinical uses are nearly identical, and their prices vary widely. However, there is no clear rational basis for the selection of these kinds of borneol in clinical applications. The purpose of this study was to clarify differences in the biological activity, safety, and structure-activity relationship of the three kinds of borneol. 'borneol', 'Bing Pian', 'Ai Pian', 'Tian Ran Bing Pian', and 'He Cheng Bing Pian' were selected as keywords to search for and extract relevant literature in the CNKI, PubMed, and Google Scholar databases up to November 2022. L-borneol has better potential in cerebrovascular diseases. The three kinds of borneol have stronger penetration-promoting effects on hydrophilic drugs. L-borneol and isoborneol promote intestinal mucosal absorption of drugs via bidirectional regulation of P-glycoprotein. D-borneol exhibits better antitumour sensitizing effects than L-borneol. L-borneol exhibits better inhibition of bacterial adhesion because of its C2 chiral centre. Synthetic borneol is less safe. L-borneol has excellent potential in many aspects, has various sources, and can effectively replace expensive D-borneol in some applications.

1 January 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QXQian Xie
Qian Xie
RMRong Ma
Rong Ma
XGXiaoqing Guo
Xiaoqing Guo
HCHai Chen
Hai Chen
JWJian Wang
Jian Wang

5 July 2024 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
RMRong Ma
Rong Ma
RLRui Li
Rui Li
JLJianlong Liang
Jianlong Liang
HYHongyan Yang
Hongyan Yang
QXQian Xie
Qian Xie
JGJialiang Guo
Jialiang Guo
Coma caused by cerebral ischemia is the most serious complication of cerebral ischemia. Four-vessel occlusion can establish a cerebral ischemic coma model ... Jove

31 May 2024 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
RMRong Ma
Rong Ma
HYHongyan Yang
Hongyan Yang
JLJianlong Liang
Jianlong Liang
DLDanni Lu
Danni Lu
QXQian Xie
Qian Xie
JGJialiang Guo
Jialiang Guo
The middle cerebral artery occlusion reperfusion (MCAO/R) model is crucial for understanding the pathological mechanisms of stroke and for drug development.However, among the commonly used modeling methods, the Koizumi method often faces scrutiny due to its ligation of the common carotid artery (CCA) and its inability to achieve adequate reperfusion. Similarly, the Longa method has been criticized for disconnecting and ligating the external carotid artery (ECA). This study aims to introduce a modified model preparation method that preserves the integrity of the ECA, involves inserting a monofilament nylon suture through the CCA, repairing the ligated CCA incision, and maintaining reperfusion from the CCA. Reperfusion of blood flow was confirmed using laser speckle flow imaging. Evaluation methods such as the Longa scale, Modified Neurological Severity Score, triphenyltetrazolium chloride (TTC) staining, and immunofluorescence labeling of neurons demonstrated that this approach could induce stable ischemic nerve damage. This modified MCAO/R model protocol is simple and stable, providing valuable guidance for practitioners in the field of cerebral ischemia.